The small organic molecule C19 binds and strengthens the KRAS4b-PDEδ complex and inhibits growth of colorectal cancer cells in vitro and in vivo
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The small organic molecule C19 binds and strengthens the KRAS4b-PDEδ complex and inhibits growth of colorectal cancer cells in vitro and in vivo
Authors
Keywords
-
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-01
DOI
10.1186/s12885-018-4968-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity
- (2018) Kai M. Brown et al. JOURNAL OF SURGICAL RESEARCH
- RAS Mutations as Predictive Biomarkers in Clinical Management of Metastatic Colorectal Cancer
- (2016) Paul Waring et al. Clinical Colorectal Cancer
- Structural basis of recognition of farnesylated and methylated KRAS4b by PDEδ
- (2016) Srisathiyanarayanan Dharmaiah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers
- (2015) Sheng-Bin Peng et al. CANCER CELL
- Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab
- (2015) S. Napolitano et al. CLINICAL CANCER RESEARCH
- First-line chemotherapy for mCRC—a review and evidence-based algorithm
- (2015) Chiara Cremolini et al. Nature Reviews Clinical Oncology
- Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance
- (2015) Markus Morkel et al. Oncotarget
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Antitumor and immunomodulatory effects of low-dose 5-FU on hepatoma 22 tumor-bearing mice
- (2014) ZHIYUN CAO et al. Oncology Letters
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
- (2013) Jonathan M. Ostrem et al. NATURE
- Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling
- (2013) Gunther Zimmermann et al. NATURE
- TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
- (2012) Anurag Singh et al. CELL
- MMPBSA.py: An Efficient Program for End-State Free Energy Calculations
- (2012) Bill R. Miller et al. Journal of Chemical Theory and Computation
- FOXO3a and β-catenin co-localization: double trouble in colon cancer?
- (2012) Yibing Yan et al. NATURE MEDICINE
- The GDI-like solubilizing factor PDEδ sustains the spatial organization and signalling of Ras family proteins
- (2011) Anchal Chandra et al. NATURE CELL BIOLOGY
- Proteolytic Cleavage of p70 Ribosomal S6 Kinase by Caspase-3 during DNA Damage-Induced Apoptosis†
- (2009) Rohini Dhar et al. BIOCHEMISTRY
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Ras oncogenes: split personalities
- (2008) Antoine E. Karnoub et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now